Danaher (NYSE:DHR) shares dipped today despite third-quarter results that came in well ahead of the consensus forecast. The Washington, D.C.-based company posted profits of $1.6 billion, or $2.10 per share, on sales of $7.7 billion for the three months ended Sept. 30, 2022, for a 35.8% bottom-line gain on sales growth of 6%. Adjusted to […]
Danaher Corp.
Danaher rises on Street-beating Q2
Danaher (NYSE:DHR) shares got a boost today on second-quarter results that came in well ahead of the consensus forecast. Shares of DHR were up 7.7% at $275.61 per share in mid-morning trading today. MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — was up 1.3%. The Washington, D.C.-based […]
Danaher beats The Street in Q1
Danaher (NYSE:DHR) shares dipped slightly today on first-quarter results that came in ahead of the consensus forecast. The Washington, D.C.-based company posted profits of $1.7 billion, or $2.31 per share, on sales of $7.7 billion for the three months ended April 1, 2022, for a 1.3% bottom-line gain on sales growth of 12.1%. Adjusted to […]
Danaher announces executive changes
Danaher (NYSE:DHR) has announced a number of personnel moves among executives at the company. SVP & chief accounting officer Robert S. Lutz notified the company that he will step down from his position as of Jan. 1, 2022, with Cristopher M. Bouda set to succeed him, Danaher announced yesterday. Bouda has served as Danaher’s VP […]
Danaher rises on Street-beating Q2
Danaher (NYSE:DHR) shares ticked up today on second-quarter results that beat the consensus forecast. The Washington, D.C.–based company posted profits of $1.7 billion, or $2.40 per share, on sales of $7.2 billion for the three months ended July 2, 2021, for a 95.5% bottom-line gain on sales growth of 36.3%. Adjusted to exclude one-time items, […]
Danaher ticks up on Street-beating Q1
Danaher (NYSE:DHR) shares rose before hours on first-quarter results that easily toppled the consensus forecast. The Washington, D.C.-based company posted profits of $1.7 billion, or $2.29 per share, on sales of $6.9 billion for the three months ended April 2, 2021, nearly tripling its bottom-line on sales growth of 57.9%. Adjusted to exclude one-time items, earnings […]
3M, Abbott in top 50 of Fortune’s most admired companies list
Medtech giants 3M (NYSE:MMM) and Abbott (NYSE:ABT) made it into the top 50 of Fortune‘s 2021 World’s Most Admired Companies list. 3M — a manufacturing conglomerate that also has one of the largest medical device businesses in the world — came in at No. 24, up from No. 29 in the 2020 list. Abbott meanwhile was No. […]
Danaher rises on Street-beating Q4
Danaher (NYSE:DHR) shares ticked up this morning on fourth-quarter results that topped the consensus forecast. The Washington, D.C.-based company posted profits of $1.2 billion, or $1.66 per share, on sales of $6.8 billion for the three months ended Dec. 31, 2020, for a -4.8% bottom-line slide on sales growth of 38.9%. Adjusted to exclude one-time items, […]
The 10 largest medical device companies in the world
Even as the world’s largest medical device companies grapple with COVID-19 and the resulting recession, they’re doing important work to help humanity manage the crisis. Read on to find out more about the 10 largest companies in the Big 100, MassDevice and Medical Design & Outsourcing’s annual analysis of the worlds’ 100 largest medical device companies. […]
Cepheid wins EUA for COVID-19, flu, RSV combination test
Cepheid announced today that it received FDA emergency use authorization for its Xpert Xpress SARS-CoV-2/Flu/RSV diagnostic test. The Danaher Corp. (NYSE:DHR) subsidiary’s rapid molecular diagnostic test for detecting the viruses causing COVID-19, Flu A, Flu B and RSV infections in a single patient can be used in tandem with any of Cepheid’s GeneXpert systems across the […]
Danaher down on inline Q1 results
Danaher posted first-quarter results that were in line with the consensus on Wall Street. The Washington, D.C.-based company reported profits of $595.1 million, or 81¢ per share on sales of $4.3 billion for the three months ended March 31, for a bottom-line gain of 78.3% sales growth of 2.9% compared with Q1 2019. Adjusted to […]
